Skip to content
Bota Biosciences logo — Deliver on nature's possibilities.

Bota Biosciences

Deliver on nature's possibilities.

Founded 2019 United States Lafayette, United States 45 employees Series B Total: $115.00M Biotechnology, Manufacturing

General Information

Company Name Bota Biosciences
Founded Year 2019
Location United States Lafayette, United States
Employees 45
Industries Biotechnology, Manufacturing
Funding Stage Series B
Business Model B2B, Platform, White Label
Revenue Model Product Sales, Project Based, Service Fee
Offices as of Oct 2026
Lafayette, United States Hangzhou, China
Social

BounceWatch is an independent company data service, not affiliated with Bota Biosciences. To contact Bota Biosciences, visit bota.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Bota Biosciences compare?

A PDF of Bota Biosciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Bota Biosciences soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Actively Hiring Oct 27, 2026

Hiring for 1 position in the last 30 days.

About Bota Biosciences

Bota Biosciences, founded in 2019, has positioned itself as a trailblazer in the intersection of biotechnology and manufacturing. Operating from its headquarters in the United States, Bota is renowned for its innovative approach to biomanufacturing through a unique Physical AI-driven paradigm. By harnessing AI, synthetic biology, and industrialization, Bota's capabilities span from strain engineering to process development, catering to industries such as food, nutrition, and personal care.

The company's slogan, "Deliver on nature's possibilities," reflects its commitment to providing scalable, green solutions and facilitating a shift towards sustainability. With a robust biofoundry platform, Bota collaborates globally to enhance productivity and efficiency in biotechnology.

In its latest funding round, Bota secured a substantial $100.00M Series B investment on 29 July 2021 from prominent investors, including Source Code Capital, Matrix Partners China, 5Y Capital, Sherpa Healthcare Partners, and Sequoia Capital China, propelling its growth trajectory and innovation efforts.

Business keywords: Physical AI, Biomanufacturing, Synthetic Biology, Strain Engineering, Process Development, Scale-up Production, Biofoundry Platform, Sustainable Solutions, Industrial Biotechnology, Biological Design, Eco-friendly Technologies, Cost-effective Biomanufacturing, Pilot Plant, Multidisciplinary Team, Global Impact

Services & Products

Biological Design
Scale-up Manufacturing
Strain and Process Optimization
Enzyme and Protein Engineering
Biopreservative and Nutritional Supplement Production

Target Customers

Food and Nutrition Industries Personal Care Industry Pharmaceutical Industry Agriculture Industry Industrial Biotechnology Applications

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $100.00M 6
Source Code Capital, Matrix Partners China +4
01 Jul 2021
Round Undisclosed -
01 Mar 2021
Series A $15.00M 2
Matrix Partners China, Sherpa Venture Partners
01 Sep 2020
Seed Undisclosed 1
Recharge Thematic Ventures
01 Feb 2020
Spinout Undisclosed 1
Massachusetts Institute of Technology
01 Jan 2019

Bota Biosciences Alternatives & Competitors

View All Alternatives
Bota Biosciences vs
Cemvita Inc.
Cemvita Inc. United States

Nature x Industry

Venture round
44 employees
Biotechnology, Energy
Bota Biosciences vs

An leading synthetic biotechnology company focusing on the green manufacturing of biodegradable plas...

Series A
15 employees
Biotechnology, Manufacturing
Bota Biosciences vs
Recircle
Recircle United Kingdom

We are a recycling and biotechnology company, working passionately together to preserve our world fo...

38 employees
Biotechnology, Manufacturing

FAQ About Bota Biosciences

Deliver on nature's possibilities.
Bota Biosciences was founded in 2019.
Bota Biosciences is headquartered in Lafayette, United States. As of Oct 2026, it also has offices in Hangzhou, China.
Bota Biosciences operates in Biotechnology and Manufacturing. Its work centres on Physical AI, Biomanufacturing, Synthetic Biology and Strain Engineering. Its customers include Food and Nutrition Industries, Personal Care Industry and Pharmaceutical Industry.
Bota Biosciences has a B2B, Platform and White Label business model. Its revenue comes from Product Sales, Project Based and Service Fee.
Bota Biosciences has approximately 45 employees.
Bota Biosciences has completed 5 funding rounds, raising a total of $115.00M. The latest funding stage is Series B.
Bota Biosciences offers: Biological Design, Scale-up Manufacturing, Strain and Process Optimization, Enzyme and Protein Engineering, Biopreservative and Nutritional Supplement Production.
Top alternatives and competitors to Bota Biosciences include Cemvita Inc., PhaBuilder, Recircle, BryoSphere Biotechnologies, Arsenale Bioyards. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Bota Biosciences and Cemvita Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Bota Biosciences, https://bouncewatch.com/company/bota-biosciences, updated 7 October 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout